Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $46.1500 (-5.91%) ($46.0500 - $49.8500) on Wed. Jun. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.76% (three month average) | RSI | 50 | Latest Price | $46.1500(-5.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.88% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-11%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.88% (StdDev 3.76%) | Hourly BBV | 0 () | Intraday Trend | -7.4% | | | |
|
Resistance Level | $47.76 | 5 Day Moving Average | $48.78(-5.39%) | 10 Day Moving Average | $49.25(-6.29%) | 20 Day Moving Average | $47.76(-3.37%) | To recent high | -10.3% | To recent low | 31.3% | Market Cap | $3.429b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |